The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 5, p. 287, doi. 10.1007/s40290-022-00438-8
- By:
- Publication type:
- Article
Works matching IS 11782595 AND DT 2022 AND VI 36 AND IP 5
Results: 7
1
2
Major Pharmaceutical Conferences and Courses: December 2022 to January 2023.
- Published in:
- 2022
- Publication type:
- Proceeding
3
Pricing and Market Access Challenges in the Era of One-Time Administration Cell and Gene Therapies.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 5, p. 265, doi. 10.1007/s40290-022-00443-x
- By:
- Publication type:
- Article
4
Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 5, p. 279, doi. 10.1007/s40290-022-00442-y
- By:
- Publication type:
- Article
5
The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 5, p. 295, doi. 10.1007/s40290-022-00441-z
- By:
- Publication type:
- Article
6
Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 5, p. 275, doi. 10.1007/s40290-022-00439-7
- By:
- Publication type:
- Article
7
Utilizing Deep Learning for Detecting Adverse Drug Events in Structured and Unstructured Regulatory Drug Data Sets.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 5, p. 307, doi. 10.1007/s40290-022-00434-y
- By:
- Publication type:
- Article